Quintiles buys Illinois cancer lab
Published: Mon, Dec. 01, 2008 02:06PM
Modified Mon, Dec. 01, 2008 02:07PM
E-Mail
Print
tool name
closeDURHAM -- Quintiles Transnational, a Durham company that helps drug-makers test and sell new medicines, has bought Targeted Molecular Diagnostics, an Illinois laboratory, to expand its ability to test cancer-fighting drugs.
TMD's technology will help Quintiles' customers better understand how their drugs work and in which populations of patients they're most likely to perform best.
Quintiles employs more than 22,000, including about 2,000 in the Triangle. The company declined to release financial terms of the deal.
More Business
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
